Tear lipocalin: Structure and function

Ocular Surface

Volumn 9, Issue 3, 2011, Pages 126-138

  Dartt, Darlene A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Lipids; Lipocalin interacting membrane receptor; Meibomian gland; Tear lipocalin; Tears

Indexed keywords

BIOLOGICAL MARKER; ENDONUCLEASE; ISOPROTEIN; LACTOFERRIN; LIGAND; LIPID; LIPOCALIN; LYSOZYME; MEMBRANE RECEPTOR; SIDEROPHORE; TEAR LIPOCALIN INTERACTING MEMBRANE RECEPTOR; TEAR PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BACTERIUM; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRY EYE; ENDOCYTOSIS; ENZYME ACTIVITY; HUMAN; HYDROPHOBICITY; LACRIMAL FLUID; LIGAND BINDING; MACROMOLECULE; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; TEAR VISCOSITY; TISSUE DISTRIBUTION; VISCOSITY;

EID: 80051755601     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(11)70022-2     Document Type: Review

References (62)

1. R edl B. Human tear lipocalin. Biochim Biophys Acta 2000;1482(1-2):241- 248
2. F lower DR. Beyond the superfamily: the lipocalin receptors. Biochim Biophys Acta 2000; 1482(1-2): 327-336
3. A kerstrom B, Flower DR, Salier JP. Lipocalins: unity in diversity. Biochim Biophys Acta 2000;1482(1-2):1-8
4. F lower DR. The lipocalin protein family: a role in cell regulation. FEBS Lett 1994;354(1):7-11
5. F lower DR. Multiple molecular recognition properties of the lipocalin protein family. J Mol Recognit 1995;8(3):185-195
6. F lower DR, North AC, Sansom CE . The lipocalin protein family:structural and sequence overview. Biochim Biophys Acta 2000;1482(1-2):9-24
7. Gutierrez G, Ganfornina MD, Sanchez D. Evolution of the lipocalin family as inferred from a protein sequence phylogeny. Biochim Biophys Acta 2000;1482(1-2):35-45
8. Grzyb J, Latowski D, Strzalka K. Lipocalins - a family portrait. J Plant Physiol 2006;163(9):895-915 (Pubitemid 44404051)
9. Pfeffer BA, Clark VM, Flannery JG, et al. Membrane receptors for retinol-binding protein in cultured human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1986;27(7):1031-1040 (Pubitemid 16062038)
10. Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 2000;1482(1-2):298-307
11. Y an L, Borregaard N, Kjeldsen L, et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL) . Modulation of MMP-9 activity by NGAL . J Biol Chem 2001;276(40):37258-65
12. Sanchez D, Ortega-Cubero S, Akerstrom B, et al. Molecular interactions of the neuronal GPI-anchored lipocalin Lazarillo. J Mol Recognit 2008;21(5):313-323
13. E rickson O. Stanford Med Bull 1956;14:124-125
14. Josephson AS, Weiner RS. Studies of the proteins of lacrimal secretions. J Immunol 1968;100:1080-1081
15. R edl B, Holzfeind P, Lottspeich F. cDNA cloning and sequencing reveals human tear prealbumin to be a member of the lipophilic-ligand carrier protein superfamily. J Biol Chem 1992;267(28): 20282-20287
16. L assagne H, Gachon AM. Cloning of a human lacrimal lipocalin secreted in tears. Exp Eye Res 1993;56:605-609
17. Breustedt DA, Korndorfer IP, Redl B, et al. The 1.8-A crystal structure of human tear lipocalin reveals an extended branched cavity with capacity for multiple ligands. J Biol Chem 2005;280:484-493 (Pubitemid 40165013)
18. Glasgow BJ. Tissue expression of lipocalins in human lacrimal and von Ebner's glands: colocalization with lysozyme. Graefes Arch Clin Exp Ophthalmol 1995;233:513-522
19. Breustedt DA, Chatwell L, Skerra A. A new crystal form of human tear lipocalin reveals high flexibility in the loop region and induced fit in the ligand cavity. Acta Crystallogr D Biol Crystallogr 2009;65(Pt 10):1118-1125
20. Gasymov OK, Abduragimov AR, Glasgow BJ. Intracavitary ligand distribution in tear lipocalin by site-directed tryptophan fluorescence. Biochemistry 2009;48:7219-7228
21. Gasymov OK, Abduragimov AR, Yusifov TN, et al. Structural changes in human tear lipocalins associated with lipid binding. Biochim Biophys Acta 1998;1386:145-156 (Pubitemid 29333226)
22. Wojnar P, Dirnhofer S, Ladurner P, et al. Human lipocalin-1, a physiological scavenger of lipophilic compounds, is produced by corticotrophs of the pituitary gland. J Histochem Cytochem 2002;50:433-435 (Pubitemid 34171066)
23. Gasymov OK, Abduragimov AR, Glasgow BJ. pH-Dependent conformational changes in tear lipocalin by site-directed tryptophan fluorescence. Biochemistry 2010; 49:582-590
24. Glasgow BJ, Gasymov OK. Focus on molecules: tear lipocalin. Exp Eye Res 2011;92:242-243
25. Gasymov OK, Abduragimov AR, Yusifov TN, et al. Interstrand loops CD and EF act as pH-dependent gates to regulate fatty acid ligand binding in tear lipocalin. Biochemistry 2004;43:12894-12904 (Pubitemid 39331809)
26. A rnoux P, Morosinotto T, Saga G, et al. A structural basis for the pH-dependent xanthophyll cycle in Arabidopsis thaliana. Plant Cell 2009;21:2036-44
27. A bduragimov AR, Gasymov OK, Yusifov TN, et al. Functional cavity dimensions of tear lipocalin. Curr Eye Res 2000;21:824-32
28. L e Danvic C, Guiraudie-Capraz G, Abderrahmani D, et al. Natural ligands of porcine olfactory binding proteins. J Chem Ecol 2009;35:741-751
29. Y ou J, Fitzgerald A, Cozzi PJ, et al. Post-translation modification of proteins in tears. Electrophoresis 2010;31:1853-61
30. Gasymov OK, Abduragimov AR, Yusifov TN, et al. Resolution of ligand positions by site-directed tryptophan fluorescence in tear lipocalin. Protein Sci 2000;9:325-331 (Pubitemid 30127005)
31. Wojnar P, van't Hof W, Merschak P, et al. The N-terminal part of recombinant human tear lipocalin/von Ebner's gland protein confers cysteine proteinase inhibition depending on the presence of the entire cystatin-like sequence motifs. Biol Chem 2001;382:1515-1520 (Pubitemid 33062238)
32. Wojnar P, Lechner M, Redl B. Antisense down-regulation of lipocalininteracting membrane receptor expression inhibits cellular internaliza- tion of lipocalin-1 in human NT2 cells. J Biol Chem 2003;278:16209-16215 (Pubitemid 36799744)
33. Wojnar P, Lechner M, Merschak P, et al. Molecular cloning of a novel lipocalin-1 interacting human cell membrane receptor using phage display. J Biol Chem 2001;276:20206-20212
34. F luckinger M, Merschak P, Hermann M, et al. Lipocalin- interactingmembrane- receptor (LIMR) mediates cellular internalization of betalactoglobulin. Biochim Biophys Acta 2008;1778:342-7
35. Zhang Z, Kim SJ, Chowdhury B, et al. Interaction of uteroglobin with lipocalin-1 receptor suppresses cancer cell motility and invasion. Gene 2006;369:66-71 (Pubitemid 43327332)
36. R edl B, Merschak P, Abt B, et al. Phage display reveals a novel interaction of human tear lipocalin and thioredoxin which is relevant for ligand binding. FEBS Lett 1999;460:182-6
37. Josephson AS, Wald A. Enhancement of lysozyme activity by anodal tear protein. Proc Soc Exp Biol Med 1969;131:677-679
38. L aktionov PP, Rykova E, Krepkii DV, et al. Interaction of oligonucleotides with barrier fluid proteins. Biochemistry (Mosc) 1997;62:613-8
39. Gasymov OK, Abduragimov AR, Yusifov TN, et al. Interaction of tear lipocalin with lysozyme and lactoferrin. Biochem Biophys Res Commun 1999;265:322-325
40. Gasymov OK, Abduragimov AR, Prasher P, et al. Tear lipocalin: evidence for a scavenging function to remove lipids from the human corneal surface. Invest Ophthalmol Vis Sci 2005;46:3589-3596 (Pubitemid 44264661)
41. Mudgil P, Millar TJ. Adsorption of apo- and holo-tear lipocalin to a bovine Meibomian lipid film. Exp Eye Res 2008;86:622-628
42. Glasgow BJ, Gasymov OK, Abduragimov AR, et al. Tear lipocalin captures exogenous lipid from abnormal corneal surfaces. Invest Ophthalmol Vis Sci 2010;51:1981-1987
43. Glasgow BJ, Marshall G, Gasymov OK, et al. Tear lipocalins: potential lipid scavengers for the corneal surface. Invest Ophthalmol Vis Sci 1999;40:3100-3107
44. Saaren-Seppala H, Jauhiainen M, Tervo TM, et al. Interaction of purified tear lipocalin with lipid membranes. Invest Ophthalmol Vis Sci 2005;46:3649-3656 (Pubitemid 44264669)
45. Gouveia SM, Tiffany JM. Human tear viscosity: an interactive role for proteins and lipids. Biochim Biophys Acta 2005;1753:155-63
46. Millar TJ, Mudgil P, Butovich IA, et al. Adsorption of human tear lipocalin to human meibomian lipid films. Invest Ophthalmol Vis Sci 2009;50:140-151
47. Tsukamoto S, Fujiwara K, Ikeguchi M. Fatty acids bound to recombinant tear lipocalin and their role in structural stabilization. J Biochem2009;146:343-50. Epub 2009 May 26
48. Glasgow BJ, Abduragimov AR, Yusifov TN, et al. A conserved disulfide motif in human tear lipocalins influences ligand binding. Biochemistry 1998;37:2215-2225 (Pubitemid 28119294)
49. H uuskonen J, Wohlfahrt G, Jauhiainen M, et al. Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis. J Lipid Res 1999;40:1123-30
50. Nishida HI, Nishida T. Phospholipid transfer protein mediates transfer of not only phosphatidylcholine but also cholesterol from phosphatidylcholine- cholesterol vesicles to high density lipoproteins. J Biol Chem 1997;272:6959-6964 (Pubitemid 27166395)
51. Bron AJ, Tiffany JM, Gouveia SM, et al. Functional aspects of the tear film lipid layer. Exp Eye Res 2004;78: 347-360 (Pubitemid 38183311)
52. Y usifov TN, Abduragimov AR, Gasymov OK, et al. Endonuclease activity in lipocalins. Biochem J 2000;347 Pt 3:815-9
53. Y usifov TN, Abduragimov AR, Narsinh K, et al. Tear lipocalin is the major endonuclease in tears. Mol Vis 2008;14:180-8
54. F luckinger M, Haas H, Merschak P, et al. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother 2004;48:3367-72
55. A nanthi S, Chitra T, Bini R, et al. Comparative analysis of the tear protein profile in mycotic keratitis patients. Mol Vis 2008;14:500-7
56. L ogdberg L, Wester L. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim Biophys Acta 2000;1482(1-2):284-297
57. Zhou L, Beuerman RW, Chan CM, et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRA Q quantitative proteomics. J Proteome Res 2009;8:4889-4905
58. C affery B, Joyce E, Boone A, et al. Tear lipocalin and lysozyme in Sjogren and non-Sjogren dry eye. Optom Vis Sci 2008;85:661-7
59. Navone R, Lunardi C, Gerli R, et al. Identification of tear lipocalin as a novel autoantigen target in Sjogren's syndrome. J Autoimmun 2005;25:229-234 (Pubitemid 41654468)
60. Qian L, Xie J, Rose CM, et al. Altered traffic to the lysosome in an ex vivo lacrimal acinar cell model for chronic muscarinic receptor stimulation. Exp Eye Res 2004;79:665-675 (Pubitemid 39410369)
61. van't Hof W, Blankenvoorde MF, Veerman EC, et al. The salivary lipocalin von Ebner's gland protein is a cysteine proteinase inhibitor. J Biol Chem 1997;272:1837-1841 (Pubitemid 27045715)
62. Breustedt DA, Schonfeld DL, Skerra A. Comparative ligand-binding analysis of ten human lipocalins. Biochim Biophys Acta 2006;1764:161-73